Everett Harris & Co. CA Sells 13,808 Shares of Colgate-Palmolive (NYSE:CL)

Everett Harris & Co. CA lowered its position in Colgate-Palmolive (NYSE:CL) by 1.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 799,625 shares of the company’s stock after selling 13,808 shares during the quarter. Colgate-Palmolive comprises approximately 1.0% of Everett Harris & Co. CA’s portfolio, making the stock its 25th largest holding. Everett Harris & Co. CA’s holdings in Colgate-Palmolive were worth $72,006,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Union Savings Bank grew its stake in Colgate-Palmolive by 76.6% in the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after buying an additional 134 shares in the last quarter. Avion Wealth increased its stake in Colgate-Palmolive by 78.1% in the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after acquiring an additional 175 shares during the last quarter. Atlantic Edge Private Wealth Management LLC purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $32,000. Core Wealth Advisors Inc. lifted its stake in Colgate-Palmolive by 56.6% during the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock worth $32,000 after purchasing an additional 146 shares during the last quarter. Finally, McGlone Suttner Wealth Management Inc. bought a new stake in Colgate-Palmolive during the fourth quarter worth about $34,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Activity

In other news, insider John W. Kooyman sold 3,497 shares of the stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the transaction, the insider now owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The disclosure for this sale can be found here. Insiders own 0.37% of the company’s stock.

Colgate-Palmolive Trading Down 0.2 %

CL traded down $0.23 during midday trading on Thursday, reaching $95.89. 2,114,672 shares of the company’s stock traded hands, compared to its average volume of 4,069,581. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $99.08. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70. The firm has a fifty day moving average of $94.31 and a two-hundred day moving average of $87.95. The stock has a market capitalization of $78.67 billion, a price-to-earnings ratio of 30.35, a P/E/G ratio of 3.54 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the prior year, the company earned $0.73 earnings per share. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. On average, equities analysts anticipate that Colgate-Palmolive will post 3.53 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.09%. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. Wells Fargo & Company raised their price objective on Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a report on Monday, April 29th. Argus boosted their price objective on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a report on Wednesday, May 15th. Bank of America upped their price objective on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, April 29th. Royal Bank of Canada lifted their target price on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Monday, April 29th. Finally, BNP Paribas initiated coverage on shares of Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 price target for the company. Three investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $93.83.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.